Significant relation of tissue inhibitor of matrix metalloproteinase-2 and its combination with matrix metalloproteinase-2 to survival of patients with cancer of uterine cervix

Po Hui Wang; Jiunn Liang Ko; Shun Fa Yang; Hsiu Ting Tsai; Yi Torng Tee; Chih Ping Han; Long Yau Lin; Shiuan Chih Chen; Yang Tse Shih

doi:10.1177/1933719111398143

Significant relation of tissue inhibitor of matrix metalloproteinase-2 and its combination with matrix metalloproteinase-2 to survival of patients with cancer of uterine cervix

Po Hui Wang, Jiunn Liang Ko, Shun Fa Yang, Hsiu Ting Tsai, Yi Torng Tee, Chih Ping Han, Long Yau Lin, Shiuan Chih Chen, Yang Tse Shih

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Abstract

Tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) has high affinity for matrix metalloproteinase-2 (MMP-2). Few studies simultaneously investigate their implication in prognosis of patients with cervical cancer. We used reverse transcription-polymerase chain reaction and immunohistochemical method for cervical tissues and microarrays to investigate the association among TIMP-2, MMP-2, clinicopathological parameters, and prognosis of patients with cancer. Our results showed that cancer tissues exhibited less TIMP-2 expression and patients with pelvic lymph node metastasis had less TIMP-2 expression. Positive TIMP-2 constellated with negative MMP-2 indicated lower recurrence probability and better overall survival. The protective effect of TIMP-2 expression may overcome the adverse effect of MMP-2 expression in terms of disease-free interval and overall survival while neither TIMP-2 nor MMP-2 alone can be used to predict outcome. We suggest that following patients other than those with positive TIMP-2 and negative MMP-2 expression more closely and intensely may improve their prognosis.

Original language	English
Pages (from-to)	798-808
Number of pages	11
Journal	Reproductive Sciences
Volume	18
Issue number	8
DOIs	https://doi.org/10.1177/1933719111398143
Publication status	Published - Aug 2011
Externally published	Yes

Keywords

cancer of uterine cervix
inhibitor of matrix metalloproteinase-2
matrix metalloproteinase -2
overall survival
recurrence probability

ASJC Scopus subject areas

Obstetrics and Gynaecology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1177/1933719111398143

Cite this

Wang, P. H., Ko, J. L., Yang, S. F., Tsai, H. T., Tee, Y. T., Han, C. P., Lin, L. Y., Chen, S. C., & Shih, Y. T. (2011). Significant relation of tissue inhibitor of matrix metalloproteinase-2 and its combination with matrix metalloproteinase-2 to survival of patients with cancer of uterine cervix. Reproductive Sciences, 18(8), 798-808. https://doi.org/10.1177/1933719111398143

@article{278d780b7511453c892dbffc8aa4ea5e,

title = "Significant relation of tissue inhibitor of matrix metalloproteinase-2 and its combination with matrix metalloproteinase-2 to survival of patients with cancer of uterine cervix",

abstract = "Tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) has high affinity for matrix metalloproteinase-2 (MMP-2). Few studies simultaneously investigate their implication in prognosis of patients with cervical cancer. We used reverse transcription-polymerase chain reaction and immunohistochemical method for cervical tissues and microarrays to investigate the association among TIMP-2, MMP-2, clinicopathological parameters, and prognosis of patients with cancer. Our results showed that cancer tissues exhibited less TIMP-2 expression and patients with pelvic lymph node metastasis had less TIMP-2 expression. Positive TIMP-2 constellated with negative MMP-2 indicated lower recurrence probability and better overall survival. The protective effect of TIMP-2 expression may overcome the adverse effect of MMP-2 expression in terms of disease-free interval and overall survival while neither TIMP-2 nor MMP-2 alone can be used to predict outcome. We suggest that following patients other than those with positive TIMP-2 and negative MMP-2 expression more closely and intensely may improve their prognosis.",

keywords = "cancer of uterine cervix, inhibitor of matrix metalloproteinase-2, matrix metalloproteinase -2, overall survival, recurrence probability",

author = "Wang, {Po Hui} and Ko, {Jiunn Liang} and Yang, {Shun Fa} and Tsai, {Hsiu Ting} and Tee, {Yi Torng} and Han, {Chih Ping} and Lin, {Long Yau} and Chen, {Shiuan Chih} and Shih, {Yang Tse}",

year = "2011",

month = aug,

doi = "10.1177/1933719111398143",

language = "English",

volume = "18",

pages = "798--808",

journal = "Reproductive Sciences",

issn = "1933-7191",

publisher = "SAGE Publications Inc.",

number = "8",

}

TY - JOUR

T1 - Significant relation of tissue inhibitor of matrix metalloproteinase-2 and its combination with matrix metalloproteinase-2 to survival of patients with cancer of uterine cervix

AU - Wang, Po Hui

AU - Ko, Jiunn Liang

AU - Yang, Shun Fa

AU - Tsai, Hsiu Ting

AU - Tee, Yi Torng

AU - Han, Chih Ping

AU - Lin, Long Yau

AU - Chen, Shiuan Chih

AU - Shih, Yang Tse

PY - 2011/8

Y1 - 2011/8

N2 - Tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) has high affinity for matrix metalloproteinase-2 (MMP-2). Few studies simultaneously investigate their implication in prognosis of patients with cervical cancer. We used reverse transcription-polymerase chain reaction and immunohistochemical method for cervical tissues and microarrays to investigate the association among TIMP-2, MMP-2, clinicopathological parameters, and prognosis of patients with cancer. Our results showed that cancer tissues exhibited less TIMP-2 expression and patients with pelvic lymph node metastasis had less TIMP-2 expression. Positive TIMP-2 constellated with negative MMP-2 indicated lower recurrence probability and better overall survival. The protective effect of TIMP-2 expression may overcome the adverse effect of MMP-2 expression in terms of disease-free interval and overall survival while neither TIMP-2 nor MMP-2 alone can be used to predict outcome. We suggest that following patients other than those with positive TIMP-2 and negative MMP-2 expression more closely and intensely may improve their prognosis.

AB - Tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) has high affinity for matrix metalloproteinase-2 (MMP-2). Few studies simultaneously investigate their implication in prognosis of patients with cervical cancer. We used reverse transcription-polymerase chain reaction and immunohistochemical method for cervical tissues and microarrays to investigate the association among TIMP-2, MMP-2, clinicopathological parameters, and prognosis of patients with cancer. Our results showed that cancer tissues exhibited less TIMP-2 expression and patients with pelvic lymph node metastasis had less TIMP-2 expression. Positive TIMP-2 constellated with negative MMP-2 indicated lower recurrence probability and better overall survival. The protective effect of TIMP-2 expression may overcome the adverse effect of MMP-2 expression in terms of disease-free interval and overall survival while neither TIMP-2 nor MMP-2 alone can be used to predict outcome. We suggest that following patients other than those with positive TIMP-2 and negative MMP-2 expression more closely and intensely may improve their prognosis.

KW - cancer of uterine cervix

KW - inhibitor of matrix metalloproteinase-2

KW - matrix metalloproteinase -2

KW - overall survival

KW - recurrence probability

UR - http://www.scopus.com/inward/record.url?scp=79961045274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79961045274&partnerID=8YFLogxK

U2 - 10.1177/1933719111398143

DO - 10.1177/1933719111398143

M3 - Article

C2 - 21422052

AN - SCOPUS:79961045274

VL - 18

SP - 798

EP - 808

JO - Reproductive Sciences

JF - Reproductive Sciences

SN - 1933-7191

IS - 8

ER -

Significant relation of tissue inhibitor of matrix metalloproteinase-2 and its combination with matrix metalloproteinase-2 to survival of patients with cancer of uterine cervix

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this